000 02099 a2200613 4500
005 20250518100523.0
264 0 _c20210426
008 202104s 0 0 eng d
022 _a1523-5866
024 7 _a10.1093/neuonc/noaa107
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBalana, Carmen
245 0 0 _aA phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
_h[electronic resource]
260 _bNeuro-oncology
_c12 2020
300 _a1851-1861 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Alkylating
_xadverse effects
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aGlioblastoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aTemozolomide
_xadverse effects
700 1 _aVaz, Maria Angeles
700 1 _aManuel Sepúlveda, Juan
700 1 _aMesia, Carlos
700 1 _aDel Barco, Sonia
700 1 _aPineda, Estela
700 1 _aMuñoz-Langa, Jose
700 1 _aEstival, Anna
700 1 _ade Las Peñas, Ramón
700 1 _aFuster, Jose
700 1 _aGironés, Regina
700 1 _aNavarro, Luis Miguel
700 1 _aGil-Gil, Miguel
700 1 _aAlonso, Miriam
700 1 _aHerrero, Ana
700 1 _aPeralta, Sergio
700 1 _aOlier, Clara
700 1 _aPerez-Segura, Pedro
700 1 _aCovela, Maria
700 1 _aMartinez-García, Maria
700 1 _aBerrocal, Alfonso
700 1 _aGallego, Oscar
700 1 _aLuque, Raquel
700 1 _aPerez-Martín, Franciso Javier
700 1 _aEsteve, Anna
700 1 _aMunne, Nuria
700 1 _aDomenech, Marta
700 1 _aVilla, Salvador
700 1 _aSanz, Carolina
700 1 _aCarrato, Cristina
773 0 _tNeuro-oncology
_gvol. 22
_gno. 12
_gp. 1851-1861
856 4 0 _uhttps://doi.org/10.1093/neuonc/noaa107
_zAvailable from publisher's website
999 _c30895004
_d30895004